Description
This session aims to educate attendees on several important clinical topics that can face people with CF. The first talk covers the diagnosis, prevention and management of venous thromboembolism in CF, as well as the potential difficulties of anticoagulant treatment. The second talk discusses strategies to identify, prevent and manage acute kidney injury, chronic kidney disease and hearing loss in CF. The third talk addresses the challenging area of antibiotic allergy and desensitization in CF. The fourth talk covers the scenario where people with CF develop non-CF disease and the difficulties that can arise when the treatment for one condition impacts on the other.
Learning Objectives:
- Summarize the pathophysiology, investigation and management of venous thromboembolism in CF.
- Summarize the pathophysiology, investigation and methods of prevention of nephrotoxicity/ototoxicity due to CF drug therapy as well as the optimal approach to antibiotic allergies/desensitization in CF
- Discuss examples of how non-CF disease can impact on the management and outcomes of CF patients
Speaker(s):
- Edward
F. Nash,
MRCP, B.Sc.,
West Midlands Adult CF Centre
- Joanne
Billings,
M.D., M.P.H.,
Assistant Professor,
University of Minnesota
- Clifford
M. Takemoto,
M.D.,
Mr.,
The Johns Hopkins University
- Alan
R. Smyth,
M.A., MBBS, MRCP, M.D., FRCPCH,
Professor of Child Health,
University of Nottingham
- Moira
Aitken,
M.D.,
Director, Adult CF Clinic; Professor,
University of Washington
- Daniel
G. Peckham,
M.R.C.P., D.M.,
St. James University Hospital
